Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Abstract 5011: Patient-derived organotypic cancer spheroids (PDOCS) as predictive models for the treatment of cancer in a clinically meaningful time frame

Cheri A. Pasch, Peter F. Favreau, Alex E. Yueh, Kwang P. Nickel, Christopher P. Babiarz, Philip B. Emmerich, Rosabella T. Pitera, Susan N. Payne, Demetra P. Korkos, Joseph T. Sharick, Carley M. Sprackling, Linda Clipson, Kristina A. Matkowskyj, Michael A. Newton, Melissa C. Skala, Michael F. Bassetti, Randall J. Kimple, Dustin A. Deming

Cancer Res (2018) 78 (13_Supplement): 5011.

https://doi.org/10.1158/1538-7445.AM2018-5011

Published: 01 July 2018

View article titled, Abstract 5011: Patient-derived organotypic cancer spheroids (PDOCS) as predictive models for the treatment of cancer in a clinically meaningful time frame

Journal Articles

Abstract 2936: MTORC1/2 inhibition in combination with BCL-2/BCL-xL inhibition in APC and PIK3CA mutant colorectal cancer

Stephanie L. Fricke, Susan N. Payne, Cheri A. Pasch, Demetra P. Korkos, Gioia Sha, Alex E. Yueh, Christopher Babiarz, Linda Clipson, Kristina A. Matkowskyj, Michael A. Newton, Dustin A. Deming

Cancer Res (2018) 78 (13_Supplement): 2936.

https://doi.org/10.1158/1538-7445.AM2018-2936

Published: 01 July 2018

View article titled, Abstract 2936: MTORC1/2 inhibition in combination with BCL-2/BCL-xL inhibition in APC and PIK3CA mutant colorectal cancer

Journal Articles

Abstract 2915: The timing of mutational burst events impact the growth of tumors in the colon

Chelsie K. Sievers, Tien N. Vo, Perry J. Pickhardt, Bryan D. Pooler, Kristina A. Matkowskyj, Dawn M. Albrecht, Quincy Rosemarie, Michael A. Newton, Richard B. Halberg

Cancer Res (2017) 77 (13_Supplement): 2915.

https://doi.org/10.1158/1538-7445.AM2017-2915

Published: 01 July 2017

View article titled, Abstract 2915: The timing of mutational burst events impact the growth of tumors in the colon

Journal Articles

Abstract 151: Modeling the rise of intratumoral heterogeneity in growing, static, and regressing human colorectal polyps

Chelsie K. Sievers, Luli Zou, Perry J. Pickhardt, Kristina A. Matkowskyj, Dawn Albrecht, David H. Kim, Fouad J. Moawad, Brooks D. Cash, Mark Reichelderfer, Michael A. Newton, Richard B. Halberg

Cancer Res (2016) 76 (14_Supplement): 151.

https://doi.org/10.1158/1538-7445.AM2016-151

Published: 15 July 2016

View article titled, Abstract 151: Modeling the rise of intratumoral heterogeneity in growing, static, and regressing human colorectal polyps

Journal Articles

Abstract 2366: Pilot study of DNA microseeding to activate immune rejection of canine melanoma

Cindy L. Zuleger, Chulhi Kang, Erik A. Ranheim, Ilene Kurzman, Michael D. Macklin, Michael A. Newton, David M. Vail, Jedd D. Wolchok, Elof Eriksson, Mark R. Albertini

Cancer Res (2016) 76 (14_Supplement): 2366.

https://doi.org/10.1158/1538-7445.AM2016-2366

Published: 15 July 2016

View article titled, Abstract 2366: Pilot study of DNA microseeding to activate immune rejection of canine melanoma

Journal Articles

Abstract 2381: A multiancestral model of colorectal cancer: in vivo evidence that early heterogeneity contributes to cancer progression

Alyssa A. Leystra, Brook Luers, Junbo Son, Chelsie K. Sievers, Amanda M. Wisinger, Alexander R. Schwartz, Christopher D. Zahm, Kristina A. Matkowskyj, Dawn M. Albrecht, Linda Clipson, Dustin A. Deming, Michael A. Newton, Richard B. Halberg

Cancer Res (2016) 76 (14_Supplement): 2381.

https://doi.org/10.1158/1538-7445.AM2016-2381

Published: 15 July 2016

View article titled, Abstract 2381: A multiancestral model of colorectal cancer: in vivo evidence that early heterogeneity contributes to cancer progression

Journal Articles

Abstract 4143: Discrete clones cooperate to promote tumor progression through a non-cell-autonomous mechanism in intestinal cancers

Alyssa A. Leystra, Amanda M. Wisinger, Christopher D. Zahm, Kristina A. Matkowskyj, Chelsie K. Sievers, Alex Schwartz, Dawn M. Albrecht, Linda Clipson, Dustin A. Deming, Michael A. Newton, Richard B. Halberg

Cancer Res (2015) 75 (15_Supplement): 4143.

https://doi.org/10.1158/1538-7445.AM2015-4143

Published: 01 August 2015

View article titled, Abstract 4143: Discrete clones cooperate to promote tumor progression through a non-cell-autonomous mechanism in intestinal cancers

Journal Articles

Abstract 1935: Transformation of epithelial cells through recruitment leads to polyclonal intestinal cancers

Alyssa A. Leystra, Dustin A. Deming, Amanda M. Wisinger, Christopher D. Zahm, Chelsie K. Sievers, Kristina A. Matkowskyj, Dawn M. Albrecht, Michael A. Newton, Richard B. Halberg

Cancer Res (2014) 74 (19_Supplement): 1935.

https://doi.org/10.1158/1538-7445.AM2014-1935

Published: 01 October 2014

View article titled, Abstract 1935: Transformation of epithelial cells through recruitment leads to polyclonal intestinal cancers

Journal Articles

Abstract 2356: Characterization of molecular signatures predicting response to 5-FU based chemotherapy in mouse models of colorectal cancer

Jamie N. Hadac, Terrah J. Paul Olson, Alyssa A. Leystra, Dawn M. Albrecht, Linda Clipson, Ruth Sullivan, Michael A. Newton, Richard B. Halberg, William R. Schelman

Cancer Res (2014) 74 (19_Supplement): 2356.

https://doi.org/10.1158/1538-7445.AM2014-2356

Published: 01 October 2014

View article titled, Abstract 2356: Characterization of molecular signatures predicting response to 5-FU based chemotherapy in mouse models of colorectal cancer

Journal Articles

Abstract 2726: Tumor progression and treatment response characterization in a novel mouse model of colon cancer.

Jamie N. Hadac, Terrah J. Paul Olson, Michael A. Newton, Gregory D. Kennedy, William R. Schelman, Richard B. Halberg

Cancer Res (2013) 73 (8_Supplement): 2726.

https://doi.org/10.1158/1538-7445.AM2013-2726

Published: 15 April 2013

View article titled, Abstract 2726: Tumor progression and treatment response characterization in a novel mouse model of colon cancer.

Journal Articles

Fundamental Differences in Cell Cycle Deregulation in Human Papillomavirus–Positive and Human Papillomavirus–Negative Head/Neck and Cervical Cancers

Dohun Pyeon, Michael A. Newton, Paul F. Lambert, Johan A. den Boon, Srikumar Sengupta, Carmen J. Marsit, Craig D. Woodworth, Joseph P. Connor, Thomas H. Haugen, Elaine M. Smith, Karl T. Kelsey, Lubomir P. Turek, Paul Ahlquist

Cancer Res (2007) 67 (10): 4605–4619.

https://doi.org/10.1158/0008-5472.CAN-06-3619

Published: 17 May 2007

View article titled, Fundamental Differences in Cell Cycle Deregulation in Human Papillomavirus–Positive and Human Papillomavirus–Negative Head/Neck and Cervical Cancers

Includes: Supplementary data

Journal Articles

Genome-Wide Expression Profiling Reveals EBV-Associated Inhibition of MHC Class I Expression in Nasopharyngeal Carcinoma

Srikumar Sengupta, Johan A. den Boon, I-How Chen, Michael A. Newton, David B. Dahl, Meng Chen, Yu-Juen Cheng, William H. Westra, Chien-Jen Chen, Allan Hildesheim, Bill Sugden, Paul Ahlquist

Cancer Res (2006) 66 (16): 7999–8006.

https://doi.org/10.1158/0008-5472.CAN-05-4399

Published: 15 August 2006

View article titled, Genome-Wide Expression Profiling Reveals EBV-Associated Inhibition of MHC Class I Expression in Nasopharyngeal Carcinoma

Includes: Supplementary data

Journal Articles

Chemopreventive Efficacy of Combined Piroxicam and Difluoromethylornithine Treatment of Apc Mutant Min Mouse Adenomas, and Selective Toxicity against Apc Mutant Embryos

Russell F. Jacoby, Carolyn E. Cole, Kendra Tutsch, Michael A. Newton, Gary Kelloff, Ernest T. Hawk, Ronald A. Lubet

Cancer Res (2000) 60 (7): 1864–1870.

Published: 01 April 2000

View article titled, Chemopreventive Efficacy of Combined Piroxicam and Difluoromethylornithine Treatment of Apc Mutant Min Mouse Adenomas, and Selective Toxicity against Apc Mutant Embryos

Journal Articles

p16/pRb Pathway Alterations Are Required for Bypassing Senescence in Human Prostate Epithelial Cells

David F. Jarrard, Somdatta Sarkar, Yan Shi, Thomas R. Yeager, Gregg Magrane, Hidefumi Kinoshita, Nadine Nassif, Lorraine Meisner, Michael A. Newton, Frederic M. Waldman, Catherine A. Reznikoff

Cancer Res (1999) 59 (12): 2957–2964.

Published: 15 June 1999

View article titled, p16/pRb Pathway Alterations Are Required for Bypassing Senescence in Human Prostate Epithelial Cells

Journal Articles

Intestinal Neoplasia in the Apc^Min Mouse: Independence from the Microbial and Natural Killer (beige Locus) Status

William F. Dove, Linda Clipson, Karen A. Gould, Cindy Luongo, David J. Marshall, Amy R. Moser, Michael A. Newton, Russell F. Jacoby

Cancer Res (1997) 57 (5): 812–814.

Published: 01 March 1997

View article titled, Intestinal Neoplasia in the ApcMin Mouse: Independence from the Microbial and Natural Killer (beige Locus) Status

Journal Articles

Chemoprevention of Spontaneous Intestinal Adenomas in the Apc ^Min Mouse Model by the Nonsteroidal Anti-inflammatory Drug Piroxicam

Russell F. Jacoby, David J. Marshall, Michael A. Newton, Kristian Novakovic, Kendra Tutsch, Carolyn E. Cole, Ronald A. Lubet, Gary J. Kelloff, Ajit Verma, Amy R. Moser, William F. Dove

Cancer Res (1996) 56 (4): 710–714.

Published: 01 February 1996

View article titled, Chemoprevention of Spontaneous Intestinal Adenomas in the Apc Min Mouse Model by the Nonsteroidal Anti-inflammatory Drug Piroxicam

NARROW

Abstract 5011: Patient-derived organotypic cancer spheroids (PDOCS) as predictive models for the treatment of cancer in a clinically meaningful time frame

Abstract 2936: MTORC1/2 inhibition in combination with BCL-2/BCL-xL inhibition in APC and PIK3CA mutant colorectal cancer

Abstract 2915: The timing of mutational burst events impact the growth of tumors in the colon

Abstract 151: Modeling the rise of intratumoral heterogeneity in growing, static, and regressing human colorectal polyps

Abstract 2366: Pilot study of DNA microseeding to activate immune rejection of canine melanoma

Abstract 2381: A multiancestral model of colorectal cancer: in vivo evidence that early heterogeneity contributes to cancer progression

Abstract 4143: Discrete clones cooperate to promote tumor progression through a non-cell-autonomous mechanism in intestinal cancers

Abstract 1935: Transformation of epithelial cells through recruitment leads to polyclonal intestinal cancers

Abstract 2356: Characterization of molecular signatures predicting response to 5-FU based chemotherapy in mouse models of colorectal cancer

Abstract 2726: Tumor progression and treatment response characterization in a novel mouse model of colon cancer.

Fundamental Differences in Cell Cycle Deregulation in Human Papillomavirus–Positive and Human Papillomavirus–Negative Head/Neck and Cervical Cancers

Genome-Wide Expression Profiling Reveals EBV-Associated Inhibition of MHC Class I Expression in Nasopharyngeal Carcinoma

Chemopreventive Efficacy of Combined Piroxicam and Difluoromethylornithine Treatment of Apc Mutant Min Mouse Adenomas, and Selective Toxicity against Apc Mutant Embryos

p16/pRb Pathway Alterations Are Required for Bypassing Senescence in Human Prostate Epithelial Cells

Intestinal Neoplasia in the Apc^Min Mouse: Independence from the Microbial and Natural Killer (beige Locus) Status

Chemoprevention of Spontaneous Intestinal Adenomas in the Apc ^Min Mouse Model by the Nonsteroidal Anti-inflammatory Drug Piroxicam

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only